Novocure

Novocure

医療機器製造業

Zug、Switzerland54,883人のフォロワー

Patient-forward: Aspiring to make a difference in cancer

概要

We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer. Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire and Chesterbrook, Pennsylvania. Additionally, Novocure has offices in Canada, Germany, Japan, Poland and Israel.

業種
医療機器製造業
会社規模
社員 1,001 - 5,000名
本社
Zug、Switzerland
種類
上場企業
創立
2000
専門分野
Medical Device、Oncology、Cancer、Glioblastoma、Neuro-Oncology

場所

Novocureの社員

アップデート

類似するページ

NVCR

NASDAQ

20分遅れ

$22.93

-1.25 (-5.17%)

未解決
24.19
22.875
24.19

データの提供元: レフィニティブ

情報をさらに表示 Bing

資金調達

Novocure 合計7ラウンド

最終ラウンド

ポストIPO債務

$100,000,000.00

投資家およびグループ

Pharmakon Advisors
Crunchbaseで詳しい情報を表示